Anti-tuberculosis effect of isoniazid scales accurately from zebrafish to humans.
Rob Christiaan van WijkWanbin HuSharka M DijkemaDirk-Jan van den BergJeremy LiuRida BahiFons J VerbeekUlrika S H SimonssonHerman P SpainkPiet H van der GraafElke H J KrekelsPublished in: British journal of pharmacology (2020)
This proof of concept study confirmed the potential of zebrafish larvae as tuberculosis disease models in translational pharmacology and contributes to innovative anti-tuberculosis drug development, which is very clearly needed.